Reversal of Obesity and Insulin Resistance by a Non-Peptidic Glucagon-Like Peptide-1 Receptor Agonist in Diet-Induced Obese Mice

• Min He,

  Affiliations The National Center for Drug Screening, Shanghai, China, The State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China

  ⨯
• Haoran Su,

  Current address: Department of Molecular and Integrative Physiology, University of Michigan, Ann Arbor, Michigan, United States of America

  Affiliation The National Center for Drug Screening, Shanghai, China

  ⨯
• Weiwei Gao,

  Affiliation The National Center for Drug Screening, Shanghai, China

  ⨯
• Stina M. Johansson,

  Current address: Department of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden

  Affiliation The National Center for Drug Screening, Shanghai, China

  ⨯
• Qing Liu,

  Affiliations The National Center for Drug Screening, Shanghai, China, The State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China

  ⨯
• Xiaoyan Wu,

  Affiliations The National Center for Drug Screening, Shanghai, China, The State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China

  ⨯
• Jiayu Liao,

  Current address: Department of Bioengineering, University of California Riverside, Riverside, California, United States of America

  Affiliation The National Center for Drug Screening, Shanghai, China

  ⨯
• Andrew A. Young,

  Current address: Enteroendocrine Biology, GlaxoSmithKline, Research Triangle Park, North Carolina, United States of America

  Affiliation The National Center for Drug Screening, Shanghai, China

  ⨯
• Tamas Bartfai,

  Affiliation Molecular and Integrative Neurosciences Department, The Scripps Research Institute, La Jolla, California, United States of America

  ⨯
• Ming-Wei Wang

  * E-mail: wangmw@mail.shcnc.ac.cn

  Affiliations The National Center for Drug Screening, Shanghai, China, The State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China, Molecular and Integrative Neurosciences Department, The Scripps Research Institute, La Jolla, California, United States of America

  ⨯